A normal LDL cholesterol level is below 100 mg/dL for adults. Levels between 100 and 129 mg/dL are considered slightly elevated, 130 to 159 mg/dL is borderline high, 160 to 189 mg/dL is high, and anything at or above 190 mg/dL is very high. But “normal” can be misleading, because the LDL target your doctor sets for you depends heavily on your overall risk for heart disease.
LDL Levels at a Glance
LDL is often called “bad” cholesterol because it carries cholesterol into your artery walls, where it can build up and eventually narrow or block blood flow. Here’s how adult levels are classified:
- Below 100 mg/dL: Optimal
- 100 to 129 mg/dL: Near optimal or slightly elevated
- 130 to 159 mg/dL: Borderline high
- 160 to 189 mg/dL: High
- 190 mg/dL or above: Very high
For children and teens (age 19 or younger), the threshold is a bit different. A healthy LDL level is below 110 mg/dL, and levels above 160 mg/dL with other risk factors may warrant closer attention.
Your Target May Be Lower Than “Normal”
Below 100 mg/dL is the general benchmark, but the 2026 ACC/AHA cholesterol guidelines reintroduced specific LDL goals tied to your individual cardiovascular risk. If you have additional risk factors or existing heart disease, “normal” isn’t low enough.
For adults at intermediate cardiovascular risk (a 5% to 10% chance of a heart event over the next 10 years), the recommended goal is below 100 mg/dL. If your risk is high (10% or greater over 10 years), the target drops to below 70 mg/dL. And for people at very high risk, meaning those who already have heart disease or have had a heart attack or stroke, the goal is below 55 mg/dL.
People with diabetes follow a similar pattern. Without existing heart disease, the target is typically below 100 mg/dL. With both diabetes and cardiovascular disease, the goal tightens to below 70 mg/dL, and sometimes lower.
How Low Is Too Low?
You might wonder whether LDL can drop too far. Research from a long-term follow-up of patients on aggressive cholesterol-lowering therapy found that cardiovascular events continued to decline even at LDL levels below 20 mg/dL, and down to a median of 7 mg/dL in some cases. The study, published in Circulation, concluded there appears to be no lower bound for LDL in terms of heart protection for high-risk patients, and no safety concerns emerged at those very low levels. For most people not on intensive therapy, this isn’t relevant, but it does mean there’s no evidence that a naturally low LDL is harmful.
How LDL Is Measured
Most cholesterol panels don’t measure LDL directly. Instead, your lab calculates it from your total cholesterol, HDL cholesterol, and triglycerides. For decades, the standard formula for this was the Friedewald equation, but it has a known weakness: it becomes less accurate when triglycerides are high or when LDL is very low.
A newer method developed at Johns Hopkins, called the Martin/Hopkins equation, correctly classified 89.6% of patients’ LDL values in a study comparing 23 different formulas. The older Friedewald method correctly classified 83.2%. The difference matters most for people at the extremes, those with high triglycerides or very low LDL, where the older formula tends to underestimate the real number. If your triglycerides are elevated and your LDL looks reassuringly low on a standard panel, the actual value could be higher than reported. Some labs now use the newer calculation, but not all do.
Direct LDL measurement, where the lab measures LDL itself rather than calculating it, is available but typically reserved for situations where accuracy is critical, such as when levels are unusually low on treatment.
Non-HDL Cholesterol: A Broader Picture
Your cholesterol panel also includes a number called non-HDL cholesterol, which is simply your total cholesterol minus your HDL. This captures not just LDL but all the other cholesterol-carrying particles that contribute to artery disease. Non-HDL cholesterol is increasingly considered a better predictor of cardiovascular risk than LDL alone, because it accounts for residual risk that remains even after LDL is well controlled.
The general rule: your non-HDL target should be no more than 30 mg/dL above your LDL target. So if your LDL goal is below 100, your non-HDL should be below 130. If your doctor has set an LDL goal of below 70, your non-HDL target is below 100. For children and teens, non-HDL below 120 mg/dL is considered healthy.
When Treatment Comes Into Play
An LDL level alone doesn’t determine whether you need medication. The decision factors in your overall 10-year cardiovascular risk, which accounts for age, blood pressure, smoking status, and diabetes alongside cholesterol numbers. The U.S. Preventive Services Task Force recommends statin therapy for adults aged 40 to 75 who have at least one cardiovascular risk factor and a 10-year event risk of 10% or greater. For those with a 7.5% to 10% risk, statins are selectively offered based on individual circumstances.
The exception is an LDL at or above 190 mg/dL. At that level, treatment is recommended regardless of calculated risk, because the cholesterol elevation itself signals very high danger, sometimes caused by a genetic condition called familial hypercholesterolemia. For adults with this level and no existing heart disease, the goal is to bring LDL below 100 mg/dL. If heart disease is already present, the target drops to below 55 mg/dL.
For children and teens, medication is generally considered only when LDL exceeds 190 mg/dL despite six months of dietary changes, or above 160 mg/dL if other risk factors for heart disease are present.